Medical Director, US Rare Cardiac, non-MD

Role Responsibilities Support development and execution of U.S. medical strategies and tactics for Vyndamax. Collaborate cross-functionally (commercial, field medical, HEOR, digital, U.S. medical information) to enhance and deliver U.S. medical plans. Serve as a Medical Affairs reviewer in the U.S. Review Committee (RC) to ensure scientific accuracy and compliance of promotional and non‑promotional materials. Act as a scientific resource on ATTR-CM disease state, clinical data, product labeling, and competitive landscape. Support and coordinate U.S. medical congress activities (coverage planning, session prioritization, onsite support). Provide scientific input for medical/educational content ensuring accuracy, clinical relevance, and strategy alignment. Support customer insights and insight‑generation activities (e.g., advisory boards) with Field Medical and internal stakeholders. Deliver therapeutic area and product training to cross‑functional colleagues. Partner with U.S. Medical Information for expert input into Medical Letters and response documents. Qualifications / Skills Doctoral degree in clinical/pharmacy (Ph.D./Pharm.D) with 5+ years; Master’s with 7+ years; Bachelor’s with 8+ years. Preferred: Heart Failure/ATTR-CM knowledge and experience. Understanding of drug development process; health care economics; strong analytical skills. Customer‑oriented, strategic thinking, deadline management, creativity/resourcefulness, strong communication/presentation skills. Other Job Details / Application Last date to apply: July 13, 2026. Work location: NYHQ. Relocation package: No. Annual base salary range: $176,600–$294,300; bonus target 20% of base; eligibility for long‑term incentives and comprehensive benefits (incl. 401(k)). #J-18808-Ljbffr Scorpion Therapeutics